109613 ⎘
dsDNA viruses; Details; Adenoviridae Viruses as such, e.g. new isolates, mutants or their genomic sequences
ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE
#2TUMOR-SELECTIVE E1A AND E1B MUTANTS
#3ANTI-GUCY2C VACCINES AND VACCINATION
#4PROGRAMMABLE RECRUITMENT OF TRANSCRIPTION FACTORS TO ENDOGENOUS GENES
#5METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#6ADENOVIRUS CONSTRUCTS AND METHODS OF USE
#7Recombinant Viral Genomes and Related Compositions and Methods
#8ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#9Adeno-Associated-Virus Rep Sequences, Vectors and Viruses
#10ADENOVIRAL SEROTYPE 35 HELPER VECTORS
#11Adenoviral Vectors
#12Simian Adenovirus and Hybrid Adenoviral Vectors
#13Targeted neoepitope vectors and methods therefor
#14PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT
#15Tumor-selective E1a and E1b mutants
#16RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UNIT AND TWO STEP TRANSCRIPTIONAL REGULATION AND AMPLIFICATION
#17Methods of treating solid or lymphatic tumors by combination therapy
#18DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS
#19Compositions And Methods For Viral Delivery Of Neoepitopes And Uses Thereof
#20Modified viruses
#21ONCOLYTIC ADENOVIRUS COMPOSITIONS
#22DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES
#23Oncolytic virus expressing PD-1 binding protein and application of oncolytic virus
#24ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#25MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS
#26METHOD FOR PRODUCING RECOMBINANT ADENOVIRUS
#27Tumor-selective E1A and E1B mutants
#28Replication-enhanced oncolytic adenoviruses
#29Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein
#30Simian adenovirus and hybrid adenoviral vectors
#31Prevention and/or treatment of hearing loss or impairment
#32Compositions and methods for viral delivery of neoepitopes and uses thereof
#33Cell line for producing adenovirus and method of preparing the same
#34ANTI-ANGIOGENIC ADENOVIRUS
#35Modified viruses
#36Targeted neoepitope vectors and methods therefor
#37Detargeted adenovirus variants and related methods
#38Adenoviral vectors
#39Adeno-associated-virus Rep sequences, vectors and viruses
#40ONCOLYTIC ADENOVIRUSES FOR CANCER TREATMENT
#41Methods and compositions for performing continuous directed evolution
#42Tumor-selective E1a and E1b mutants
#43ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#44Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
#45Compositions and methods for viral delivery of neoepitopes and uses thereof
#46METHODS FOR TREATMENT OF CANCER
#47Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
#48Modified serotype 28 adenoviral vectors
#49Detargeted adenovirus variants and related methods
#50Prevention and/or treatment of hearing loss or impairment
#51Simian adenovirus and hybrid adenoviral vectors
#52LncRNA and oncolytic adenovirus, and application thereof
#53A PROCESS FOR THE PRODUCTION OF ADENOVIRUS
#54PPSA and Pspa polymer-virus complex and pharmaceutical compositions comprising the same
#55Microcin and uses thereof
#56Oncolytic adenoviruses for cancer treatment
#57Conditionally replicating adenovirus
#58Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)
#59Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#60Adenovirus isolated from titi monkeys
#61Dosing regime and formulations for type B adenovirus
#62A PROCESS FOR THE PRODUCTION OF ADENOVIRUS
#63RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS
#64TUMOR-SELECTIVE E1A AND E1B MUTANTS
#65Adeno-associated-virus Rep sequences, vectors and viruses
#66Oncolytic adenovirus compositions
#67Immunogenic compositions comprising silicified virus and methods of use
#68Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#69Recombinant serotype 5 (Ad5) adenoviral vectors
#70ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#71Modified serotype 28 adenoviral vectors
#72Microcin and uses thereof
#73Oncolytic Adenoviruses for Cancer Treatment
#74Simian adenovirus and hybrid adenoviral vectors
#75Chimeric adenoviruses for use in cancer treatment
#76Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#77Chimeric adenoviruses for use in cancer treatment
#78Chimeric adenoviruses for use in cancer treatment
#79Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#80Chimeric adenoviruses for use in cancer treatment
#81Tumor selective E1a and E1b mutants
#82Malaria antigen screening method
#83Adenoviral vectors and methods and uses related thereto
#84Oncolytic Adenoviruses for Cancer Treatment
#85Chimeric adenoviruses for use in cancer treatment
#86Chimeric adenoviruses for use in cancer treatment